November 23, 2010
China is one of the world’s key growth markets and an equally promising future has been forecast for the Russian pharma market. Gerresheimer recognised this...
February 09, 2010
Sales on like-for-like basis almost at prior year level (-1.5 percent)
Adjusted EBITDA margin of 19.2 percent (on like-for-like basis) better than expected